Risk model for morbidity and mortality following liver surgery based on a national Japanese database
- PMID: 39229562
- PMCID: PMC11368509
- DOI: 10.1002/ags3.12803
Risk model for morbidity and mortality following liver surgery based on a national Japanese database
Abstract
Aim: We evaluated the morbidity and mortality associated with liver surgery in Japan and developed a risk model for liver resection using information from a national database.
Methods: We retrospectively reviewed 73 861 Japanese patients who underwent hepatectomy between 2014 and 2019, using information from the National Clinical Database (NCD) registrations. The primary endpoints were 30 days and in-hospital mortality, and the secondary endpoints were postoperative complications. Logistic regression risk models for postoperative morbidity and mortality after hepatectomy were constructed based on preoperative clinical parameters and types of liver resection, and validated using a bootstrapping method.
Results: The 30-day and in-hospital mortality rates were 0.9% and 1.7%, respectively. Trisectionectomy, hepatectomy for gallbladder cancer, hepatectomy for perihilar cholangiocarcinoma, and poor activities of daily living were statistically significant risk factors with high odds ratios for both postoperative morbidity and mortality. Internal validations indicated that the c-indices for 30-day and in-hospital mortality were 0.824 and 0.839, respectively.
Conclusions: We developed a risk model for liver resection by using a national surgical database that can predict morbidity and mortality based on preoperative factors.
Keywords: hepatectomy; liver resection; morbidity; mortality; risk model.
© 2024 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery.
Conflict of interest statement
Hiroaki Miyata is affiliated with the Department of Healthcare Quality Assessment at the University of Tokyo. The department is a social collaboration department supported by grants from the National Clinical Database, Johnson & Johnson K.K, Nipro Corporation, and Intuitive Surgical Sàrl. Shinya Hirakawa and Hisateru Tachimori belong to an endowed course of Keio University funded by Takeda Pharmaceutical Company Limited and belong to the Department of Healthcare Quality Assessment at the University of Tokyo that accepts financial support from National Clinical Database, Johnson & Johnson K.K., Nipro Corporation, and Intuitive Surgical Sàrl. But Dr Miyata, Dr Hirakawa, and Dr Tachimori have no conflicts of interest regarding this research. The other authors declare no conflicts of interest regarding this research. Dr. Yoshihiro Kakeji and Dr. Ken Shirabe are editorial members of Annals of Gastroenterological Surgery.
Figures
References
-
- Dimick JB, Wainess RM, Cowan JA, Upchurch GR Jr, Knol JA. Colletti LM.J improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. J Am Coll Surg. 2004;199:31–38. - PMC - PubMed
-
- Sasaki A, Tachimori H, Akiyama Y, Oshikiri T, Miyata H, Kakeji Y, et al. Risk model for mortality associated with esophagectomy via a thoracic approach based on data from the Japanese National Clinical Database on malignant esophageal tumors. Surg Today. 2023;53(1):73–81. - PubMed
LinkOut - more resources
Full Text Sources
